Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Onyx Pharma submits NDA for carfilzomib in relapsed and refractory multiple myeloma
Onyx Pharma submits NDA for carfilzomib in relapsed and refractory multiple myeloma
Onyx Pharma submits NDA for carfilzomib in relapsed and refractory multiple myeloma
Submitted by
admin
on October 2, 2011 - 12:35pm
Source:
Pharmabiz
News Tags:
ONYX Pharmaceuticals
Carfilzomib
proteasome inhibitors
Multiple Myeloma
Headline:
Onyx Pharma submits NDA for carfilzomib in relapsed and refractory multiple myeloma
Do Not Allow Advertisers to Use My Personal information
